ProfileGDS4718 / 205524_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 47% 51% 50% 51% 46% 53% 48% 50% 53% 49% 49% 49% 44% 52% 51% 49% 46% 45% 46% 50% 57% 55% 53% 49% 47% 55% 43% 46% 48% 47% 48% 48% 51% 47% 47% 45% 49% 48% 39% 49% 46% 44% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5161150
GSM549102patient 115, normal, homogenized [OPG study]5.3743847
GSM549104patient 119, normal, homogenized [OPG study]5.5810851
GSM549108patient 138, normal, homogenized [OPG study]5.5465950
GSM549119patient 077, normal, homogenized [OPG study]5.5820351
GSM549133patient 032, cancer, homogenized [OPG study]5.23546
GSM549139patient 042, cancer, homogenized [OPG study]5.6799853
GSM549099patient 107, normal, homogenized [OPG study]5.416548
GSM549109patient 139, normal, homogenized [OPG study]5.5157750
GSM549110patient 046, normal, homogenized [OPG study]5.6574253
GSM549114patient 063, normal, homogenized [OPG study]5.3909149
GSM549122patient 082, normal, homogenized [OPG study]5.4441249
GSM549134patient 033, cancer, homogenized [OPG study]5.4180549
GSM549136patient 036, cancer, homogenized [OPG study]5.1296344
GSM549140patient 044, cancer, homogenized [OPG study]5.6255752
GSM549111patient 047, normal, homogenized [OPG study]5.5298751
GSM549113patient 057, normal, homogenized [OPG study]5.3809349
GSM549132patient 031, cancer, homogenized [OPG study]5.3117746
GSM549137patient 038, cancer, homogenized [OPG study]5.2149345
GSM549142patient 047, cancer, homogenized [OPG study]5.4033146
GSM549100patient 110, normal, homogenized [OPG study]5.5302350
GSM549107patient 135, normal, homogenized [OPG study]5.9242557
GSM549115patient 068, normal, homogenized [OPG study]5.7473455
GSM549116patient 072, normal, homogenized [OPG study]5.6409253
GSM549120patient 078, normal, homogenized [OPG study]5.4683449
GSM549131patient 030, cancer, homogenized [OPG study]5.3014947
GSM549118patient 074, normal, homogenized [OPG study]5.8035455
GSM549129patient 027, cancer, homogenized [OPG study]5.1768743
GSM549123patient 088, normal, homogenized [OPG study]5.2718546
GSM549124patient 006, cancer, homogenized [OPG study]5.4498348
GSM549126patient 015, cancer, homogenized [OPG study]5.3132947
GSM549128patient 025, cancer, homogenized [OPG study]5.4150548
GSM549103patient 117, normal, homogenized [OPG study]5.4802148
GSM549117patient 073, normal, homogenized [OPG study]5.5096651
GSM549138patient 041, cancer, homogenized [OPG study]5.3443347
GSM549141patient 045, cancer, homogenized [OPG study]5.314847
GSM549130patient 028, cancer, homogenized [OPG study]5.2656445
GSM549101patient 111, normal, homogenized [OPG study]5.5127249
GSM549105patient 128, normal, homogenized [OPG study]5.404748
GSM549106patient 134, normal, homogenized [OPG study]4.9051339
GSM549112patient 048, normal, homogenized [OPG study]5.4669849
GSM549125patient 011, cancer, homogenized [OPG study]5.3192846
GSM549127patient 024, cancer, homogenized [OPG study]5.177744
GSM549135patient 035, cancer, homogenized [OPG study]5.3163947